ReviewRSC advances2021
Recent developments in the nanomaterial-catalyzed green synthesis of structurally diverse 1,4-dihydropyridines.
Review in RSC advances, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed.
- Novel Synergistic Synthesis of Ni-Doped FeACS omega · 2025Article
- Montmorillonite K-10 catalyzed synthesis of Hantzsch dihydropyridine derivatives from methyl arenesRSC advances · 2024Article
- Synthesis of hydrazone-based polyhydroquinoline derivatives - antibacterial activities, α-glucosidase inhibitory capability, and DFT study.RSC advances · 2024Article
- Facile One-Pot Synthesis and Anti-Microbial Activity of Novel 1,4-Dihydropyridine Derivatives in Aqueous Micellar Solution under Microwave Irradiation.Molecules (Basel, Switzerland) · 2024Article
- Construction of 1,4-Dihydropyridines: The Evolution of C4 Source.Topics in current chemistry (Cham) · 2023Review
- Tandem Protocol of Hexahydroquinoline Synthesis Using [HACS omega · 2023Article
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
1,4-Dihydropyridine (1,4-DHP), a privileged heterocyclic scaffold, has been extensively utilized in various biological and therapeutic applications. In this review article, we discussed the role of different nano-catalysts, nanoflakes, nanocomposites, and other green-supported nanomaterials in the synthesis of a biologically active and vital pharmaceutical precursor 1,4-DHP and its derivatives such as polyhydroquinoline, benzopyranopyridines, and dihydropyridine since 2015. It is evident that although the use of various tailored nanostructures under different conditions to optimize the synthesis of 1,4-DHP and its compounds has provided sustainable and efficient proposals, yet the development of greener practices in the synthesis of 1,4-DHPs, which can be applied to design new synthetic routes and sequences in process development, is a far-reaching task to be accomplished.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.